Clinical Trial Update: Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma

View source ↗

Summary

This clinical trial update discusses using seizure control as a new metric to assess the efficacy of tumor treatment in patients with low-grade glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Glioma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Brain Neoplasm, Low Grade Glioma | Status: ACTIVE_NOT_RECRUITING